Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels.
about
Emerging PSA-based tests to improve screeningValidation of proposed prostate cancer biomarkers with gene expression data: a long road to travelRole of YY1 in the pathogenesis of prostate cancer and correlation with bioinformatic data sets of gene expressionPSA and Prostate Health Index based prostate cancer screening in a hereditary migration complicated population: implications in precision diagnosis.Overexpression of α (1,6) fucosyltransferase associated with aggressive prostate cancer.Novel diagnostic biomarkers for prostate cancer.Whole prostate volume and shape changes with the use of an inflatable and flexible endorectal coilInitial biopsy outcome prediction in Korean patients-comparison of a noble web-based Korean prostate cancer risk calculator versus prostate-specific antigen testing.Detection of Alpha-Methylacyl-CoA Racemase (AMACR), a Biomarker of Prostate Cancer, in Patient Blood Samples Using a Nanoparticle Electrochemical Biosensor.Serum prostate-specific antigen levels and type of work in tire manufacturing workers.Prostate biopsy for the interventional radiologistProstate Cancer Can Be Detected Even in Patients with Decreased PSA Less than 2.5 ng/ml after Treatment of Chronic Prostatitis.Association between systemic inflammatory markers and serum prostate-specific antigen in men without prostatic disease - the 2001-2008 National Health and Nutrition Examination Survey.Repeating the measurement of prostate-specific antigen in symptomatic men can avoid unnecessary prostatic biopsy.Determining variables for repeat prostate biopsy.A prospective study of reducing unnecessary prostate biopsy in patients with high serum prostate-specific antigen with consideration of prostatic inflammationEffect of prostatitis on lower urinary tract symptoms: retrospective analysis of prostate biopsy tissue.Characterization of the seminal plasma proteome in men with prostatitis by mass spectrometry.Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancer.A Review on the Clinical Utility of PSA in Cancer ProstateDevelopment and External Validation of the Korean Prostate Cancer Risk Calculator for High-Grade Prostate Cancer: Comparison with Two Western Risk Calculators in an Asian CohortThe Prostate Health Index: Its Utility in Prostate Cancer DetectionA Panel of MicroRNAs as Diagnostic Biomarkers for the Identification of Prostate CancerDoes Rigid Cystoscopy Affect the Total Serum Prostate-Specific Antigen Levels?Does normalizing PSA after successful treatment of chronic prostatitis with high PSA value exclude prostatic biopsy?Sixteen-year longitudinal changes in serum prostate-specific antigen levels: the olmsted county studyIncreased oncogenic microRNA-18a expression in the peripheral blood of patients with prostate cancer: A potential novel non-invasive biomarker.Performance of tPSA and f/tPSA for prostate cancer in Chinese. A systematic review and meta-analysis.Does PSA reduction after antibiotic therapy permits postpone prostate biopsy in asymptomatic men with PSA levels between 4 and 10 ng/mL?The effect of antibiotherapy on prostate-specific antigen levels and prostate biopsy results in patients with levels 2.5 to 10 ng/mLThe issue of prostate cancer evaluation in men with elevated prostate-specific antigen and chronic prostatitis.Incidence of histological prostatitis and its correlation with PSA density.Quantitative liver-specific protein fingerprint in blood: a signature for hepatotoxicity.Chronic prostatitis/chronic pelvic pain syndrome: the role of an antifungal regimen.Neutrophil gelatinase-associated lipocalin as a screening test in prostate cancer.Inflammatory changes in biopsy specimens from patients with suspected prostate cancer.Prostate-specific antigen screening: proThe effect of bicycling on PSA levels: a systematic review and meta-analysis.Association between systemic inflammation and serum prostate-specific antigen in a healthy Korean population.Splice variant transcripts of the anterior gradient 2 gene as a marker of prostate cancer.
P2860
Q26828563-E85F8D1A-A843-408F-97DD-D9140D519E37Q27001399-54F2D526-7AAF-4E8B-B3CC-5E036FD8C6E1Q30838103-D737AE1A-FF1C-40A6-9B51-3FD082360B3EQ33776728-200B2F65-D277-4352-BC31-FF9C4678213AQ34129290-E923A927-8893-46FD-A653-B578B620AAA7Q34231678-0996C1B4-5F0B-4AB2-ABEB-A8E507456E57Q34412631-9F03DDB1-FEAA-4FB3-8941-0A8021B566D5Q34451940-7C78C16D-8365-43AA-ACF1-CCAD182D9A79Q34680813-9E3DAEB3-224F-4CB0-90FF-730D11285DCCQ34787613-106D9CDE-EFD8-4AEE-9DD1-8F69002EF114Q35019408-12537216-B064-49F0-AD69-66F66A9CA91AQ35151989-EDF4D47C-0748-4235-981B-EBF96CF1D6B1Q35236584-EA215DDE-02E6-448D-81E5-00BC8A161F1EQ35591116-0EECC850-9CB9-4F53-BB0C-D808EC910A1EQ35679770-7B32E5CE-D7E7-4DFB-AF90-A3585091A771Q35738225-CDEF2B34-0C01-43DE-867B-E3DD34FC45DEQ35775413-2E6C2D1B-18EC-49FF-8CCC-C55103B822E1Q35834330-CF9AB636-7FAB-4974-AF76-C8CE423D0D56Q35956281-859F955F-D2EB-4358-87E9-1AE7C47C9E16Q36084063-218A449D-5A84-48F3-8D57-62855524F0B4Q36238237-F61E1C5B-A76C-42B6-A5D3-18A76480C1D8Q36328005-06E5496E-BF4C-4D3D-BCB7-F2FA9E0926A6Q36407203-87C5C612-2347-48C4-9355-2C192BBD7080Q36408671-2A0A4C6A-2D43-4CCC-995B-15BC3282FA9BQ36450786-4E2CB070-FFF6-41A9-A6B9-30ED3425B864Q36512827-0221BDCA-684A-4646-9E56-A75726822BE9Q36524546-D4F75005-D1D9-484E-80AD-7DB580B1647AQ36574557-C1FCDC5F-7214-4365-B682-6A9AEF059883Q36575823-93A0B3D8-F326-4A7B-BE70-5924BA6AD2BEQ37089968-4B6743BE-40ED-4577-B983-BA0B4D52EC0CQ37108756-81EBFF87-A091-421E-B584-521164441490Q37428491-414B71A6-8D2C-496A-B454-F49F3D0F3655Q37511138-D2AD2606-3CD3-42A1-98EC-70F09BA512A2Q37605659-51AE6B6C-DED9-4157-826C-1E57EBC26F3CQ37671600-CE7BED56-6368-4F7E-97C4-51AB652F1456Q37682420-23EF454E-10EB-4290-8792-D593F51A90DCQ37707943-4D01144A-5676-4D32-8A09-7334889D382AQ38457991-F69449C8-A3FC-4771-9498-FCAE377ABE66Q38598711-920825C1-8E5F-48EB-9DD6-68A4EB415E2FQ38955091-70EAE285-CA30-45E1-A139-6370F87BABB5
P2860
Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels.
description
1995 nî lūn-bûn
@nan
1995 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Effect of inflammation and ben ...... state specific antigen levels.
@ast
Effect of inflammation and ben ...... state specific antigen levels.
@en
Effect of inflammation and ben ...... state specific antigen levels.
@nl
type
label
Effect of inflammation and ben ...... state specific antigen levels.
@ast
Effect of inflammation and ben ...... state specific antigen levels.
@en
Effect of inflammation and ben ...... state specific antigen levels.
@nl
prefLabel
Effect of inflammation and ben ...... state specific antigen levels.
@ast
Effect of inflammation and ben ...... state specific antigen levels.
@en
Effect of inflammation and ben ...... state specific antigen levels.
@nl
P2093
P1476
Effect of inflammation and ben ...... state specific antigen levels.
@en
P2093
Catalona WJ
Humphrey PA
Ratliff TL
P304
P356
10.1097/00005392-199508000-00023
P407
P433
P577
1995-08-01T00:00:00Z